Skip to main content
Caplight Logo









Cube Biotech

Cube Biotech

Private
MonheimHealthcare & Life Scienceshttps://cube-biotech.com

Last Round

M&A

Nov 3, 2021

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cube Biotech is a biotechnology company that provides products and contract research organization (CRO) services for protein expression, purification, characterization, and stabilization to the pharmaceutical and biotech industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

protein purificationmembrane proteinaffinity chromatographycontract research organizationCROprotein expressionmagnetic beadsstructural biologylab reagentsbiotech consumablesprotein stabilizationdrug discoverywet lab serviceschromatography resinsproteomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cube Biotech Comparables

Compare Cube Biotech with similar companies based on industry and business-model similarity.

Cube Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Protein Ark
82%
Bio-Works Technologies
80%
Agarose Bead Technologies
79%

Cube Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&ANov 3, 2021
Series ADec 1, 2012

Key People

Founding team and executive leadership

Barbara Maertens

Co-Founder And COO At Cube Biotech, Managing Director

Founding Team

Roland Fabis

CTO And Co-Founder At Cube Biotech

Founding Team

Michael Bencak

CEO

Executive Team

Cube Biotech Investors

Notable investors and investment history

Cube Biotech investors
InvestorRounds
Creathor VentureSeries A
ARCHIMEDM&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 26, 2.4x the trailing average.

  • Jun 20, 2026

    Monthly visitors increased 30% MoM to 37.1K.

Cube Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cube Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cube Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersMonheim
Employee Range59
Year Founded2012
Last FundingNov 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?